News on 3SBio from BioPortfolio.com http://www.BioPortfolio.com Consolidated 3SBio news from BioPortfolio.com Tue, 09 Feb 2010 22:39:59 GMT en 3SBio Gains China Rights to Another Dialysis Drughttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033820&HITNO=0&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033820&THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4033820&HITNO=0&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4033820&THISHREF=http://c.moreover.com/click/here.pl%3fz2535413965%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSeeking Alpha: 3SBio and Panacor Bioscience sign collaboration and licensing agreementhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035567&HITNO=1&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035567&THISHREF=http://c.moreover.com/click/here.pl%3fz2536275183%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035567&HITNO=1&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035567&THISHREF=http://c.moreover.com/click/here.pl%3fz2536275183%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: 3SBio and Panacor Bioscience Enter Collaboration and License Agre...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028545&HITNO=2&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028545&THISHREF=http://c.moreover.com/click/here.pl%3fz2532759039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028545&HITNO=2&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028545&THISHREF=http://c.moreover.com/click/here.pl%3fz2532759039%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028625&HITNO=3&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028625&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028625&HITNO=3&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028625&THISHREF=http://c.moreover.com/click/here.pl%3fz2532789014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(Rhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028329&HITNO=4&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028329&THISHREF=http://c.moreover.com/click/here.pl%3fz2532686041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028329&HITNO=4&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028329&THISHREF=http://c.moreover.com/click/here.pl%3fz2532686041%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBenzinga.com: 3SBio signs development agreement with Panacor Bioscience for Nep...http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031030&HITNO=5&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031030&THISHREF=http://c.moreover.com/click/here.pl%3fz2533944591%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031030&HITNO=5&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031030&THISHREF=http://c.moreover.com/click/here.pl%3fz2533944591%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028308&HITNO=6&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028308&THISHREF=http://c.moreover.com/click/here.pl%3fz2532672444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028308&HITNO=6&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028308&THISHREF=http://c.moreover.com/click/here.pl%3fz2532672444%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hypehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028217&HITNO=7&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028217&THISHREF=http://c.moreover.com/click/here.pl%3fz2532634221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028217&HITNO=7&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028217&THISHREF=http://c.moreover.com/click/here.pl%3fz2532634221%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsBlaze: 3SBio and Panacor Bioscience Enter Collaboration and Licensehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028278&HITNO=8&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028278&THISHREF=http://c.moreover.com/click/here.pl%3fz2532658687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028278&HITNO=8&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028278&THISHREF=http://c.moreover.com/click/here.pl%3fz2532658687%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire via MSN Money: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028245&HITNO=9&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028245&THISHREF=http://c.moreover.com/click/here.pl%3fz2532641162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028245&HITNO=9&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028245&THISHREF=http://c.moreover.com/click/here.pl%3fz2532641162%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFinanzNachrichten.de: 3SBio signs development agreement with Panacor Bioscience for Nephoxil(R)http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031328&HITNO=10&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031328&THISHREF=http://c.moreover.com/click/here.pl%3fz2534140367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031328&HITNO=10&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031328&THISHREF=http://c.moreover.com/click/here.pl%3fz2534140367%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029304&HITNO=11&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029304&THISHREF=http://c.moreover.com/click/here.pl%3fz2533076584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029304&HITNO=11&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029304&THISHREF=http://c.moreover.com/click/here.pl%3fz2533076584%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPuget Sound Business Journal: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029213&HITNO=12&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029213&THISHREF=http://c.moreover.com/click/here.pl%3fz2533031308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029213&HITNO=12&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029213&THISHREF=http://c.moreover.com/click/here.pl%3fz2533031308%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBusiness Journal of Jacksonville: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029112&HITNO=13&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029112&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029112&HITNO=13&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029112&THISHREF=http://c.moreover.com/click/here.pl%3fz2533004281%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: 3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemiahttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029091&HITNO=14&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029091&THISHREF=http://c.moreover.com/click/here.pl%3fz2532995641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4029091&HITNO=14&MSIZE=71&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=3SBio&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4029091&THISHREF=http://c.moreover.com/click/here.pl%3fz2532995641%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comColumbus Business First: